Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy: Results From a Danish Multicentre Study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy : Results From a Danish Multicentre Study. / Lawaetz, Martin; Sandholt, Benjamin; Eilersen, Emilie N.; Petersen, Christian; Tørslev, Katrine; Shilenok, Dmitriy; Houlind, Kim C.; Sillesen, Henrik; Shahidi, Saeid; Rathenborg, Lisbet K.; Eiberg, Jonas.
I: European Journal of Vascular and Endovascular Surgery, Bind 62, Nr. 2, 2021, s. 160-166.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Low Risk of Neurological Recurrence while Awaiting Carotid Endarterectomy
T2 - Results From a Danish Multicentre Study
AU - Lawaetz, Martin
AU - Sandholt, Benjamin
AU - Eilersen, Emilie N.
AU - Petersen, Christian
AU - Tørslev, Katrine
AU - Shilenok, Dmitriy
AU - Houlind, Kim C.
AU - Sillesen, Henrik
AU - Shahidi, Saeid
AU - Rathenborg, Lisbet K.
AU - Eiberg, Jonas
N1 - Publisher Copyright: © 2021 European Society for Vascular Surgery
PY - 2021
Y1 - 2021
N2 - Objective: The risk of ipsilateral neurological recurrence (NR) was assessed in patients awaiting carotid endarterectomy (CEA) due to symptomatic carotid artery stenosis and whether current national guidelines of performing CEA within 14 days are adequate in present day practice. Methods: This was a retrospective multicentre observational cohort study. Patients scheduled for CEA due to symptomatic carotid artery stenosis in a five year period, 1 January 2014 to 31 December 2018, from four centres were included. Data from the Danish Vascular Registry (www.karbase.dk), operative managing systems, and electronic medical records were reviewed. Results: In total, 1 125 patients scheduled for CEA were included and 1 095 (97%) underwent the planned surgery. During a median delay from index event to CEA of 11 days (interquartile range 8–16 days), 40 patients (3.6%; 95% confidence interval [CI] 2.5%–5%) experienced a NR. One third were minor strokes (n = 12, 30%); half were transient ischaemic attacks (TIA) (n = 22, 55%); and amaurosis fugax accounted for 15% (n = 6). Twenty-six (2%) CEA procedures was cancelled, of which one was due to a disabling recurrent ischaemic event (aphasia). There were no deaths or major strokes in the waiting time for CEA. Best medical treatment (BMT) with platelet inhibitory or anticoagulation drugs and a statin was initiated in nearly all patients (98%) at first assessment. The overall 30 day risk of a post-operative major event (death or stroke) was (Kaplan–Meier [KM] estimate) 2.7% (95% CI 1.8–3.8), and not significantly correlated with the timing of surgery. Most (69%) occurred within the first three days. One, two, and three year mortality rate for CEA patients was (KM estimate) 4.8%, 7.8%, and 11.5% respectively. Conclusion: In symptomatic carotid artery stenosis patients awaiting CEA, very few NRs occurred within 14 days. Institution of immediate BMT in specialised TIA/stroke units followed by early, but not necessarily urgent, CEA is a reasonable course of action in patients with high grade symptomatic carotid artery stenosis.
AB - Objective: The risk of ipsilateral neurological recurrence (NR) was assessed in patients awaiting carotid endarterectomy (CEA) due to symptomatic carotid artery stenosis and whether current national guidelines of performing CEA within 14 days are adequate in present day practice. Methods: This was a retrospective multicentre observational cohort study. Patients scheduled for CEA due to symptomatic carotid artery stenosis in a five year period, 1 January 2014 to 31 December 2018, from four centres were included. Data from the Danish Vascular Registry (www.karbase.dk), operative managing systems, and electronic medical records were reviewed. Results: In total, 1 125 patients scheduled for CEA were included and 1 095 (97%) underwent the planned surgery. During a median delay from index event to CEA of 11 days (interquartile range 8–16 days), 40 patients (3.6%; 95% confidence interval [CI] 2.5%–5%) experienced a NR. One third were minor strokes (n = 12, 30%); half were transient ischaemic attacks (TIA) (n = 22, 55%); and amaurosis fugax accounted for 15% (n = 6). Twenty-six (2%) CEA procedures was cancelled, of which one was due to a disabling recurrent ischaemic event (aphasia). There were no deaths or major strokes in the waiting time for CEA. Best medical treatment (BMT) with platelet inhibitory or anticoagulation drugs and a statin was initiated in nearly all patients (98%) at first assessment. The overall 30 day risk of a post-operative major event (death or stroke) was (Kaplan–Meier [KM] estimate) 2.7% (95% CI 1.8–3.8), and not significantly correlated with the timing of surgery. Most (69%) occurred within the first three days. One, two, and three year mortality rate for CEA patients was (KM estimate) 4.8%, 7.8%, and 11.5% respectively. Conclusion: In symptomatic carotid artery stenosis patients awaiting CEA, very few NRs occurred within 14 days. Institution of immediate BMT in specialised TIA/stroke units followed by early, but not necessarily urgent, CEA is a reasonable course of action in patients with high grade symptomatic carotid artery stenosis.
KW - Carotid artery
KW - Carotid stenosis
KW - Endarterectomy
KW - NR
KW - Recurrent event
KW - Stroke
U2 - 10.1016/j.ejvs.2021.04.016
DO - 10.1016/j.ejvs.2021.04.016
M3 - Journal article
C2 - 34127375
AN - SCOPUS:85107907222
VL - 62
SP - 160
EP - 166
JO - European Journal of Vascular and Endovascular Surgery
JF - European Journal of Vascular and Endovascular Surgery
SN - 1078-5884
IS - 2
ER -
ID: 273651416